Comparison of medium to long-term outcomes of acute severe ulcerative colitis patients receiving accelerated and standard infliximab induction

被引：10

作者：

Gibson, David J. ^{[1
]}

Doherty, Jayne ^{[1
]}

McNally, Mairead ^{[2
]}

Campion, John ^{[3
]}

Keegan, Denise ^{[1
]}

Keogh, Aine ^{[2
]}

Kennedy, Una ^{[3
]}

Byrne, Kathryn ^{[1
]}

Egan, Laurence J. ^{[2
,4
]}

McKiernan, Susan ^{[3
]}

MacCarthy, FInbar ^{[3
]}

Sengupta, Subhasish ^{[5
]}

Sheridan, Juliette ^{[1
]}

Mulcahy, Hugh E. ^{[1
]}

Cullen, Garret ^{[1
]}

Slattery, Eoin ^{[2
]}

Kevans, David ^{[3
]}

Doherty, Glen A. ^{[1
]}

机构：

[1] St Vincents Univ Hosp, Ctr Colorectal Dis, Dept Gastroenterol, Dublin, Ireland

[2] Univ Hosp Galway, Dept Gastroenterol, Galway, Ireland

[3] St James Hosp, Dept Gastroenterol, Dublin, Ireland

[4] Natl Univ Ireland Galway, Dept Pharmacol & Therapeut, Galway, Ireland

[5] Our Lady Lourdes Hosp, Dept Gastroenterol, Drogheda, Ireland

来源：

FRONTLINE GASTROENTEROLOGY | 2020年 / 11卷 / 06期

关键词：

RESCUE THERAPY; COLECTOMY;

D O I：

10.1136/flgastro-2019-101335

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Introduction Accelerated dose infliximab (IFX) induction is associated with reduced short-term colectomy rate in acute severe ulcerative colitis (ASUC). Data on medium/long-term outcomes of this strategy are limited. Aims Evaluate medium/long-term outcomes in patients receiving IFX induction for ASUC, comparing accelerated dose (AD) and standard dose (SD) induction. Methods Retrospective study of consecutive patients admitted with corticosteroid-refractory ASUC in four tertiary referral centres within INITIative IBD research network (www. initiativeibd.ie). IFX rescue was given either as SD (weeks 0, 2, 6) or AD (<28 days) from January 2010 to September 2017. AD induction has been utilised in participating centres since 2014. Consequently SD patients were subdivided based on time period of IFX rescue: historical SD group (SD1) (2010-2013) and current SD group (SD2) (2014-2017). Primary endpoint was time to colectomy; secondary endpoint was time to IFX discontinuation if induction was complete. Results 145 patients received rescue IFX (AD=58, SD1=32, SD2=55). Disease severity at induction was comparable between AD and SD1 groups; however, SD2 group had less severe disease: median C-reactive protein (CRP) 39, 44 and 20 mg/L for AD, SD1 and SD2 groups, respectively (p=0.026, Kruskal-Wallis); median CRP: albumin ratio was 1.4, 1.8 and 0.6 (p=0.016). Median follow-up for AD, SD1 and SD2 groups was 1.6 (IQR 1.1-3.1), 4.9 (IQR 2.6-5.5) and 1.5 (IQR 0.9-2.3) years. Time to colectomy was shorter in SD1 (log rank p=0.0013); no significant difference in time to colectomy was observed comparing AD and SD2 groups (log rank p=0.32). 123 patients (84%) completed IFX induction and received maintenance therapy. Time to IFX discontinuation was shorter in SD1 (log rank p=0.009). Conclusion Time to colectomy is significantly prolonged with use of AD IFX in selected ASUC patients with more severe disease. Historical use of standard IFX induction for all ASUC patients is associated with inferior long-term outcomes.

引用

页码：441 / 447

页数：7

共 16 条

[1] Exploration of Predictive Biomarkers of Early Infliximab Response in Acute Severe Colitis: A Prospective Pilot Study [J].

Beswick, Lauren ;

Rosella, Ourania ;

Rosella, Gennaro ;

Headon, Belinda ;

Sparrow, Miles P. ;

Gibson, Peter R. ;

van Langenberg, Daniel R. .

JOURNAL OF CROHNS & COLITIS, 2018, 12 (03) :289-297

[2] Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis [J].

Brandse, Johannan F. ;

van den Brink, Gijs R. ;

Wildenberg, Manon E. ;

van der Kleij, Desiree ;

Rispens, Theo ;

Jansen, Jeroen M. ;

Mathot, Ron A. ;

Ponsioen, Cyriel Y. ;

Lowenberg, Mark ;

D'Haens, Geert R. A. M. .

GASTROENTEROLOGY, 2015, 149 (02) :350-+

[3]

Choy MC, 2018, CLIN THERAPY OBSERVA

[4] CRP/Albumin Ratio: An Early Predictor of Steroid Responsiveness in Acute Severe Ulcerative Colitis [J].

Gibson, David J. ;

Hartery, Karen ;

Doherty, Jayne ;

Nolan, Jack ;

Keegan, Denise ;

Byrne, Kathryn ;

Martin, Sean T. ;

Buckley, Maire ;

Sheridan, Juliette ;

Horgan, Gareth ;

Mulcahy, Hugh E. ;

Cullen, Garret ;

Doherty, Glen A. .

JOURNAL OF CLINICAL GASTROENTEROLOGY, 2018, 52 (06) :E48-E52

[5] An Accelerated Infliximab Induction Regimen Reduces the Need for Early Colectomy in Patients With Acute Severe Ulcerative Colitis [J].

Gibson, David J. ;

Heetun, Zaid S. ;

Redmond, Ciaran E. ;

Nanda, Kavin S. ;

Keegan, Denise ;

Byrne, Kathryn ;

Mulcahy, Hugh E. ;

Cullen, Garret ;

Doherty, Glen A. .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (02) :330-U170

[6] Accelerated Dosing of Infliximab Prevents Colectomy Within 90 Days in Only Half of Patients With Severe Ulcerative Colitis [J].

Govani, Shail M. ;

Waljee, Akbar K. ;

Stidham, Ryan W. ;

Higgins, Peter ;

Hardiman, Karin .

GASTROENTEROLOGY, 2016, 150 (04) :S106-S106

[7] Pushing the Pedal to the Metal: Should We Accelerate Infliximab Therapy for Patients With Severe Ulcerative Colitis? [J].

Herfarth, Hans H. ;

Rogler, Gerhard .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (02) :336-338

[8] Infliximab as rescue therapy in severe to moderately severe ulcerative colitis:: A randomized, placebo-controlled study [J].

Järnerot, G ;

Hertervig, E ;

Friis-Liby, I ;

Blomquist, L ;

Karlé, P ;

Grännö, C ;

Vilien, M ;

Ström, M ;

Danielsson, Å ;

Verbaan, H ;

Hellström, PM ;

Magnuson, A ;

Curman, B .

GASTROENTEROLOGY, 2005, 128 (07) :1805-1811

[9] Accelerated Clearance of Infliximab is Associated With Treatment Failure in Patients With Corticosteroid-Refractory Acute Ulcerative Colitis [J].

Kevans, David ;

Murthy, Sanjay ;

Mould, Diane R. ;

Silverberg, Mark S. .

JOURNAL OF CROHNS & COLITIS, 2018, 12 (06) :662-669

[10] Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab [J].

Laharie, D. ;

Bourreille, A. ;

Branche, J. ;

Allez, M. ;

Bouhnik, Y. ;

Filippi, J. ;

Zerbib, F. ;

Savoye, G. ;

Vuitton, L. ;

Moreau, J. ;

Amiot, A. ;

Cosnes, J. ;

Ricart, E. ;

Dewit, O. ;

Lopez-Sanroman, A. ;

Fumery, M. ;

Carbonnel, F. ;

Bommelaer, G. ;

Coffin, B. ;

Roblin, X. ;

van Assche, G. ;

Esteve, M. ;

Farkkila, M. ;

Gisbert, J. P. ;

Marteau, P. ;

Nahon, S. ;

de Vos, M. ;

Lambert, J. ;

Mary, J. Y. ;

Louis, E. .

GUT, 2018, 67 (02) :237-243

← 1 2 →